CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
about
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targetsComplexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaPromoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomasMolecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer developmentPromoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerA CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2).A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylationGene expression profiling of epithelial ovarian tumours correlated with malignant potentialThe DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control studyDown-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter regionAntineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.Epigenetics and inheritance of phenotype variation in livestockEmerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancersPolycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic ImplicationsA perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomicsEpigenetic Impact on EBV Associated B-Cell LymphomagenesisThe quest for an effective and safe personalized cell therapy using epigenetic toolsA human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-αA new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinomaMeCP2: the chromatin connection and beyondIncreased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinomaAKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activityClinical implications of interferon-γ genetic and epigenetic variantsThe complexity of the Nrf2 pathway: beyond the antioxidant responseHigh-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistancePromoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancerAnalysis of distribution of DNA methylation in kidney-renal-clear-cell-carcinoma specific genes using entropyChanges in DNA Methylation in Mouse Lungs after a Single Intra-Tracheal Administration of NanomaterialsKaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China.Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements.Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cellsDNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.Promoter DNA hypermethylation and gene repression in undifferentiated Arabidopsis cellsPcG proteins, DNA methylation, and gene repression by chromatin looping.Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
P2860
Q21245727-CD1EFF71-9468-4CFF-A340-8A64E5E56812Q24289423-C62A142A-8754-455C-8BCD-BBA84F5C04E2Q24539231-461D31C0-B62B-49FB-8DD8-A7BDE708AF29Q24603535-1F597B0B-8D2B-47EE-A88A-68D69E5309BBQ24616554-0C6CAC9C-4BBB-41F6-A398-AA24E24899E6Q24652213-4E458D50-2B14-4F28-9EC0-F29E3F434A02Q24792846-E3DB7368-1E3A-4B3F-8703-803E82FC3583Q24794741-D18F9949-7EFB-4CD8-B999-A49945213B49Q24801375-F7DE3F67-CE18-4DB1-A347-AE35BC9BC14DQ24805553-5B991EAB-09D0-4E7B-8760-09844855BD8DQ24806265-147A8591-F051-4AF1-B7D5-C6802609EAF8Q24810666-B92A0356-48AB-48DC-8DBE-4807CDC94D58Q25255934-6A4FC984-8441-4539-BF1C-94A99A1EA229Q26742131-50E43AEC-DCF0-4D4F-9099-F8F1DB3DE782Q26753851-EAEBC58B-06DA-408F-A8FF-25C494E6280CQ26801380-3B420908-A114-4465-8D07-F262B1201758Q26852571-E1492143-B130-48C0-B69E-BCDB5DBC77A1Q28068361-8441847B-EF50-4E6C-A6A4-5C57ADAD2D4CQ28079389-AE2CF9DF-8014-4806-BE65-8FD231DBB679Q28115094-873C1132-D3C4-49F5-8D57-D60FD4B495E4Q28247365-9DA8CC8E-8855-4F4A-9CEB-53C3681DA335Q28256925-A4AB0D90-E6F4-4EAD-B2EF-E4BB463C3D94Q28259846-3724148B-91C6-4325-ADC5-FF4B4277F7E1Q28272449-EBFA6ABA-721A-47AA-B76A-2CA59987C2DFQ28383437-8A4F2C29-EDEC-4AD2-A6D7-E785B3B1E382Q28389296-2D9C5792-F6D2-40B7-9EC2-BB84951C7E6CQ28474284-7D9C944C-C2CF-4080-8235-29B659427D96Q28477572-A9561E64-B17B-44C8-9D7B-947FC4302503Q28821026-B4F6AB10-46EB-49B1-8B59-9C22B5978BA3Q29248387-6591C083-E42B-44BD-BDB6-CF871DFCA8E2Q30369871-A2296C52-CE41-4011-90E6-E9C28E494226Q30885681-0447A5E6-4B74-474F-891C-10322928B1DBQ31056438-46B8A498-B540-4A1B-8B47-5E333004BCEBQ33289807-C69DD58C-39D8-43DA-A52C-1EDBDC93AA02Q33298863-9298CACB-AFB2-4152-AC73-09EC9F508307Q33308310-F1370545-8824-43A4-9518-B9C0860A20EDQ33360111-45CE5588-2432-4B1E-987E-08F81727EA45Q33373064-F7286619-BD73-457E-8FE9-39DFE01E6EADQ33389249-163C25ED-944E-4F9D-8B87-926929668614Q33406808-12B9B553-C0FD-42F6-A1E8-217616C2C61F
P2860
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CpG island hypermethylation an ...... ng present, a brighter future.
@ast
CpG island hypermethylation an ...... ng present, a brighter future.
@en
CpG island hypermethylation an ...... ng present, a brighter future.
@nl
type
label
CpG island hypermethylation an ...... ng present, a brighter future.
@ast
CpG island hypermethylation an ...... ng present, a brighter future.
@en
CpG island hypermethylation an ...... ng present, a brighter future.
@nl
prefLabel
CpG island hypermethylation an ...... ng present, a brighter future.
@ast
CpG island hypermethylation an ...... ng present, a brighter future.
@en
CpG island hypermethylation an ...... ng present, a brighter future.
@nl
P2860
P356
P1433
P1476
CpG island hypermethylation an ...... ng present, a brighter future.
@en
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205600
P407
P577
2002-08-01T00:00:00Z
P5875
P6179
1019338154